The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza: A Randomized Trial
Abstract
BACKGROUND: Observational studies from Asia suggest that maxingshigan-yinqiaosan may be effective in the treatment of acute H1N1 influenza. OBJECTIVE: To compare the efficacy and safety of oseltamivir and maxingshigan-yinqiaosan in treating uncomplicated H1N1 influenza. DESIGN: Prospective, nonblinded, randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00935194) SETTING: Eleven hospitals from 4 provinces in China. PATIENTS: 410 persons [corrected] aged 15 to 69 [corrected] years with laboratory-confirmed H1N1 influenza. INTERVENTION: Oseltamivir, 75 mg twice daily; maxingshigan-yinqiaosan decoction (composed of 12 Chinese herbal medicines, including honey-fried Herba Ephedrae), 200 mL 4 times daily; oseltamivir plus maxingshigan-yinqiaosan; or no intervention (control). Interventions and control were given for 5 days. MEASUREMENTS: Primary outcome was time to fever resolution. Secondary outcomes included symptom scores and viral shedding determined by using real-time reverse transcriptase polymerase chain reaction. RESULTS: Significant reductions in the estimated median time to fever resolution compared with the control group (26.0 hours [95% CI, 24.0 to 33.0 hours]) were seen with oseltamivir (34% [95% CI, 20% to 46%]; P < 0.001), maxingshigan-yinqiaosan (37% [CI, 23% to 49%]; P < 0.001), and oseltamivir plus maxingshigan-yinqiaosan (47% [CI, 35% to 56%]; P < 0.001). Time to fever resolution was reduced by 19% (CI, 0.3% to 34%; P = 0.05) with oseltamivir plus maxingshigan-yinqiaosan compared with oseltamivir. The interventions and control did not differ in terms of decrease in symptom scores (P = 0.38). Two patients who received maxingshigan-yinqiaosan reported nausea and vomiting. LIMITATIONS: Participants were young and had mild H1N1 influenza virus infection. Missing viral data precluded definitive conclusions about viral shedding. CONCLUSION: Oseltamivir and maxingshigan-yinqiaosan, alone and in combination, reduced time to fever resolution in patients with H1N1 influenza virus infection. These data suggest that maxingshigan-yinqiaosan may be used as an alternative treatment of H1N1 influenza virus infection. PRIMARY FUNDING SOURCE: Beijing Science and Technology Project and Beijing Nova Program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Neuraminidase Inhibitors for Influenza
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,094
Treanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R. G., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,014
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.
Ginsberg, M. M., Hopkins, J., Maroufi, A., Dunne, G., Sunega, D. R., Giessick, J., McVay, P., Lopez, K., Kriner, P., Munday, S. W., et al. (2009) · PubMed · Cited by 840
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
Nicholson, K., Aoki, F., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, C., Rode, A., Kinnersley, N., & Ward, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02288-1 · Cited by 785
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
Cao, B., Li, X.-W., Mao, Y., Wang, J., Lu, H.-Z., Chen, Y.-S., Liang, Z.-A., Liang, L., Zhang, S.-J., Zhang, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906612 · Cited by 590
Self-citationInfections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan, N. J. (2009) · JAMA · doi:10.1001/jama.2009.294 · Cited by 527
Jefferson, T., Jones, M., Doshi, P., & Del Mar, C. (2009) · BMJ · doi:10.1136/bmj.b5106 · Cited by 363
Cited by
Luo, H., Tang, Q.-L., Shang, Y.-X., Liang, S.-B., Yang, M., Robinson, N., & Liu, J.-P. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3192-6 · Cited by 613
Huang, K., Zhang, P., Zhang, Z., Youn, J. Y., Wang, C., Zhang, H., & Cai, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107843 · Cited by 552
Self-citationAir pollution and chronic airway diseases: what should people know and do?
Jiang, X., Mei, X., & Feng, D. (2016) · PubMed · doi:10.3978/j.issn.2072-1439.2015.11.50 · Cited by 433
Cheng, C.-W., Wu, T.-X., Shang, H.-C., Li, Y.-P., Altman, D. G., Moher, D., Bian, Z.-X., & for the CONSORT-CHM Formulas 2017 Group* (2017) · Annals of Internal Medicine · doi:10.7326/m16-2977 · Cited by 323
Fung, F. Y., & Linn, Y. C. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/425037 · Cited by 167
“Aprospective, nonblinded, randomized, controlled, multicenter trial was conducted in young patients in eleven hospitals from 4 provinces in China to compare the efficacy and safety of Oseltamivir and a TCM decoction “Maxingshigan-Yinqiaosan” in treating uncomplicated H1N1 influenza [26].”
Background
Metadata
- Authors
- Wang, C., Cao, B., Liu, Q.-Q., Zou, Z.-Q., Liang, Z.-A., Gu, L., Dong, J.-P., Liang, L.-R., Li, X.-W., Hu, K., He, X.-S., Sun, Y.-H., An, Y., Yang, T., Cao, Z.-X., Guo, Y.-M., Wen, X.-M., Wang, Y.-G., Liu, Y.-L., & Jiang, L.-D.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2011-08-16
- Volume
- 155
- Issue
- 4
- Pages
- 217-225
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2010581642
- Cited by
- 262
- References
- 20
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza: A Randomized Trial. https://app.cochat.ai/papers/10.7326/0003-4819-155-4-201108160-00005
- The paper
- Wang, C., Cao, B., Liu, Q.-Q., Zou, Z.-Q., Liang, Z.-A., Gu, L., Dong, J.-P., Liang, L.-R., Li, X.-W., Hu, K., He, X.-S., Sun, Y.-H., An, Y., Yang, T., Cao, Z.-X., Guo, Y.-M., Wen, X.-M., Wang, Y.-G., Liu, Y.-L., & Jiang, L.-D. (2011). Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza: A Randomized Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-155-4-201108160-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.